Cargando…
Registry of patients with multiple sclerosis and COVID-19 infection in Saudi Arabia
BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread and developed as a pandemic threatening global health. Patients with multiple sclerosis (MS)–an autoimmune demyelinating inflammatory disease of the central nervous system (CNS)–are predominantly treated with immunomo...
Autores principales: | Alshamrani, Foziah, Alnajashi, Hind, AlJumah, Mohammed, Almuaigel, Mohammad, Almalik, Yaser, Makkawi, Seraj, Alsalman, Sadiq, Almejally, Mousa, Qureshi, Shireen, Aljarallah, Salman, AlKhawajah, Nuha, Kedah, Hanaa, Alotaibi, Hessa, Saeedi, Jameelah, Alamri, Abdulla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103739/ https://www.ncbi.nlm.nih.gov/pubmed/34049217 http://dx.doi.org/10.1016/j.msard.2021.103004 |
Ejemplares similares
-
Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia
por: Al Jumah, Mohammed, et al.
Publicado: (2021) -
Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab
por: Craner, Matthew, et al.
Publicado: (2022) -
Efficacy and Safety of Intravenous Cladribine in Patients with Rapidly Evolving or Early Secondary Progressive Multiple Sclerosis
por: Alshamrani, Foziah, et al.
Publicado: (2020) -
Family Planning for People with Multiple Sclerosis in Saudi Arabia: an Expert Consensus
por: Al Jumah, Mohammed, et al.
Publicado: (2021) -
Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know
por: AlJumah, Mohamed, et al.
Publicado: (2020)